Dr. Sandel-Fernandez’s research is focused on predicting impulsive and risk behaviors as they occur in people’s daily lives. She has conducted numerous studies using ecological momentary assessment (EMA) and self-monitoring data from therapy to build person-specific models of symptom dynamics including self-harm, substance use, and suicide attempts.
Dr. Sandel-Fernandez often takes an idiographic (person-specific) analysis approach to answer the question of when in time a person is most at risk for engaging in behaviors they would like to avoid, based on their context, emotions, and personal triggers. Her career goal is to improve treatment outcomes by tailoring evidence-based care to people’s diverse symptom experiences.
Hello! I’m the medical director for the Long Term Civil Commitment Units at the Center for Behavioral Health and Learning. This is a new program as of July 2024 and I am excited to help get it off the ground. I completed my medical school training at the University of Cincinnati, then residency at Oregon Health & Science University, then addiction psychiatry fellowship at UW, then worked at the Puget Sound VA for five years and Providence Swedish for six years prior to starting at UW. I’m thrilled to be part of the team here and looking forward to this next chapter in my career.
I am currently the Medical Director at the Garvey Institute Center for Neuromodulation and am providing leadership to help grow our portfolio in the area of Neuromodulation and Interventional Psychiatry. Before coming to the UW, I was the Muriel Harris Chair of Geriatric Psychiatry and Professor of Clinical Psychiatry at UCLA. While at UCLA, I held many administrative, clinical and teaching leadership positions including serving as Medical Director of Inpatient Geriatric Psychiatry, Chief of Staff of the UCLA Neuropsychiatric Hospital, Founding Faculty of the UCLA Neuromodulation Division, Medical Director of the ECT and Interventional Psychiatry Program, among others.
I recently became Editor-in-Chief of the Journal of ECT and Related Therapies, the official publication of the International Society of ECT and Neurostimulation. My research projects have included investigating various neuromodulation and interventional therapies and developing novel educational programs and curricula. I have an abiding interest in mentoring and helping faculty at the start of their careers and a commitment to fostering the advancement of women and underrepresented minority (URM) faculty in academic medicine.
I am an Acting Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington. I received my MD, MPH from the University of Nebraska Medical Center and completed my adult residency at the University of Washington where I was chief resident. I then went on to complete a fellowship in Consultation-Liaison Psychiatry at the University of Washington. I am currently on faculty at Harborview Medical Center on the inpatient psychiatry unit and inpatient psychiatry consult service. I have a longstanding interest in the intersection between medicine and psychiatry and in working with people who suffer from serious mental illness and treatment-resistant conditions. I have clinical interests in ECT, psychopharmacology, co-morbid medical conditions, and adjunctive psychotherapies. I value caring for the whole person through thorough and accurate diagnosis, treating co-morbid medical conditions, and minimizing medications when possible. I have teaching interests in reducing stigma surrounding serious mental illness and educating residents and medical students about psychiatric care.
Personal Statement
I am a Professor of Psychiatry and Director of the Addictions Division in the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine in Seattle, Washington. I am also the clinical director of addictions treatment services at Harborview Medical Center, and work in the psychiatric rehabilitation and recovery services.
I am board-certified in Psychiatry by the American Board of Psychiatry and Neurology with Added Qualifications in Addiction Psychiatry, and the American Board of Addiction Medicine. A Distinguished Fellow of the American Psychiatric Association and a Fellow of the American Society of Addiction Medicine, I am on the editorial board and a reviewer for several scientific journals and holds a number of research grants from the National Institute of Health.
Personal Statement
My primary interest is on determining how behavioral technologies can be used to improve alcohol and drug abuse outcomes for those suffering from addiction health disparities. Behavioral technologies are non-talk therapy approaches to addiction treatment, such as motivational incentives where we provide rewards for people who abstain from or reduce their drinking. This low-cost, strength based approach to addiction can be implemented in low-resources settings by non clinicians. In fact, our group is investigating how smartphones might be used to implement this treatment, allowing us to reach the millions of individuals suffering from alcohol problems worldwide.
My second research interest in evaluating the accuracy of alcohol biomarkers in addiction treatment settings. These include alcohol urine tests, such as ethyl glucuronide (EtG) and mobile phone linked Bluetooth breathalyzers. These tools allow us to accurately assess the success of alcohol treatments, as well as provide valuable research tools.
Importantly all of my research studies are conducted in collaboration with two communities that suffer disproportionately high rates of alcohol and drug misuse, 1) adults with severe mental illnesses, like schizophrenia and bipolar disorder and 2) American Indians and Alaska Natives. My research team and I work closely with community partners who are providing addiction treatment to these populations with the goal of reducing the burden of alcohol and drug use in these communities.
Personal Statement
I am a Professor in the Division of Child Psychiatry, Department of Psychiatry and Behavioral Sciences, at the University of Washington, and the Medical Director of Child Study and Treatment Center, the State Hospital for children and adolescents in Washington State. My primary research focus addresses the genetics of neuropsychiatric disorders. Our research supports that a substantial portion of neuropsychiatric disease, including schizophrenia and autism, stems from individually rare deleterious mutations in genes important for brain development. My clinical research addresses the diagnosis and treatment of early-onset psychotic illnesses. I authored the American Academy of Child and Adolescent Psychiatry’s diagnostic and treatment guidelines for schizophrenia and bipolar disorder.
Personal Statement
I am the Psychiatry Chief of Service for both campuses of the University of Washington Medical Center. I also direct our Psychiatric Consultation and Telepsychiatry Program. My clinical focus is on patients who are hospitalized with simultaneous psychiatric and medical issues. Academically, I most often teach psychiatry trainees about psychopharmacology for refractory mood, anxiety, and psychotic disorders.
Personal Statement
I am a Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine, and the Director of the Division of Population Health. I am also a Core Investigator at the HSR&D Center for Innovation for Veteran-Centered and Value-Driven Care at the VA Puget Sound Health Care System, and the Director of the VA Virtual Care QUERI Program.
For the last 35 years, my research has focused on access to care. I have published a framework for conceptualizing access to care in the digital age that incorporates virtual care technologies. I have conducted clinical trials to test the effectiveness of virtual care technologies to facilitate the delivery of evidence-based mental health services in rural primary care clinics. I have also conducted implementation trials to test the effectiveness of strategies to promote the uptake of virtual care technologies by primary care patients and providers. My research has been supported by NIMH, NIAAA, PCORI, and VA HSR/QUERI.
Personal Statement
I am a board certified psychiatrist and work at Fred Hutchinson Cancer Center. I am a Clinical Assistant Professor of Psychiatry and Behavioral Sciences at the University of Washington. I obtained a fellowship in consultation-liaison psychiatry, a specialty that focuses on providing psychiatric care for people with complex medical conditions. My primary clinical focus is people with cancer.
I love my work. Being ill is a vulnerable time and my goal is to ease suffering and provide a sense of connection and understanding for all I work with. I believe in working collaboratively with patients and families. We work together to identify what the goals of treatment are. I have expertise in diagnosis, psychopharmacology and psychotherapy and adapt my recommendations to best serve the goals of the person before me.
I am also passionate about education. I am the site director at Fred Hutch Cancer Center for our Psycho-oncology Fellowship Program. I supervise Cl fellows, addiction fellows, psychiatry residents and provide education to social workers and psychology trainees.
